Blog

Direct-to-patient clinical trials are removing traditional barriers to research participation by bringing study activities into patients' homes. Through partnerships that combine virtual site operations with global medication delivery, trials can now reach more diverse populations while reducing travel burdens and accelerating enrollment. Read on to learn how Science 37 and Catalent are making this possible.

Cognizant, in collaboration with research KOLs from Australia, delves into the impact of Teletrials in Australia and how these hybrid, decentralized model of trials are bringing novel therapies closer to regional, rural and remote Australians. Teletrials promise to be a global case study on how public health can be promoted at a national level. Download this insightful publication and learn about the steps being taken by Australian Teletrial Program (ATP) to promote teletrials, point of view from Cognizant on how intelligent tech and process alignment can further enhance efficacy of teletrials and real world use cases of teletrials.

With 80% of trials failing to recruit enough patients and an explosion of recruitment vendors, how do you choose the right partner? This framework breaks down the landscape, from creative agencies to AI-driven technology, and reveals why success depends on understanding patient motivation, not just operations. Read on to discover how to select strategies that build trust and remove barriers.

Sites juggle multiple studies and endless questions, but the clear guidance they need often lags behind. Explore why timely answers and stronger communication are essential to keeping trials running smoothly.